missing translation for 'onlineSavingsMsg'
Learn More

Prominin-1 (CD133) Mouse anti-Human , Clone: CMab-43, BD Biosciences™

Product Code. 17247614
Change view
Click to view available options
Quantity:
0.1 mg
Unit Size:
100µg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Product Code. Quantity unitSize
17247614 0.1 mg 100µg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
This item is not returnable. View return policy
Product Code. 17247614 Supplier BD Biosciences Supplier No. 566794
 Restricted Item
Estimated Shipment: 27-08-2026
Add to basket
Add to basket
This item is not returnable. View return policy

Mouse Monoclonal Antibody

Prominin-1 (CD133) Monoclonal antibody specifically detects Prominin-1 (CD133) in Human samples. It is validated for Flow Cytometry, Immunofluorescence, Immunohistochemistry (Paraffin), Western Blot
TRUSTED_SUSTAINABILITY

Specifications

Antigen Prominin-1 (CD133)
Applications Flow Cytometry, Immunofluorescence, Immunohistochemistry (Paraffin), Western Blot
Classification Monoclonal
Clone CMab-43
Formulation Aqueous buffered solution containing ≤0.09% sodium azide.
Gene Alias PROM1; PROML1; hProminin; AC133; MCDR2; STGD4; CORD12; MSTP061; RP41
Host Species Mouse
Immunogen Human Prominin-1 Transfected Cell Line
Quantity 0.1 mg
Regulatory Status RUO
Primary or Secondary Primary
Target Species Human
Content And Storage Store undiluted at 4°C. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.
Form Purified
Isotype IgG2a κ
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.